Susquehanna International Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66M | Buy |
260,987
+92,363
| +55% | +$1.29M | ﹤0.01% | 1618 |
|
|
2025
Q1 | $2.64M | Buy |
168,624
+104,523
| +163% | +$1.63M | ﹤0.01% | 1921 |
|
|
2024
Q4 | $893K | Buy |
64,101
+13,814
| +27% | +$192K | ﹤0.01% | 3171 |
|
|
2024
Q3 | $468K | Sell |
50,287
-4,396
| -8% | -$40.9K | ﹤0.01% | 3740 |
|
|
2024
Q2 | $509K | Sell |
54,683
-45,538
| -45% | -$424K | ﹤0.01% | 3496 |
|
|
2024
Q1 | $993K | Sell |
100,221
-228,656
| -70% | -$2.27M | ﹤0.01% | 2661 |
|
|
2023
Q4 | $1.06M | Buy |
328,877
+290,584
| +759% | +$939K | ﹤0.01% | 2789 |
|
|
2023
Q3 | $203K | Buy |
38,293
+23,412
| +157% | +$124K | ﹤0.01% | 4530 |
|
|
2023
Q2 | $142K | Sell |
14,881
-91,473
| -86% | -$872K | ﹤0.01% | 4832 |
|
|
2023
Q1 | $1.17M | Buy |
106,354
+84,052
| +377% | +$925K | ﹤0.01% | 2668 |
|
|
2022
Q4 | $330K | Sell |
22,302
-38,193
| -63% | -$565K | ﹤0.01% | 3779 |
|
|
2022
Q3 | $1.16M | Buy |
60,495
+25,814
| +74% | +$493K | ﹤0.01% | 2345 |
|
|
2022
Q2 | $739K | Buy |
34,681
+15,249
| +78% | +$325K | ﹤0.01% | 2824 |
|
|
2022
Q1 | $374K | Sell |
19,432
-2,935
| -13% | -$56.5K | ﹤0.01% | 4083 |
|
|
2021
Q4 | $464K | Sell |
22,367
-1,168
| -5% | -$24.2K | ﹤0.01% | 3912 |
|
|
2021
Q3 | $562K | Buy |
23,535
+4,945
| +27% | +$118K | ﹤0.01% | 3526 |
|
|
2021
Q2 | $507K | Sell |
18,590
-16,412
| -47% | -$448K | ﹤0.01% | 3879 |
|
|
2021
Q1 | $1.01M | Buy |
35,002
+23,828
| +213% | +$690K | ﹤0.01% | 2985 |
|
|
2020
Q4 | $314K | Sell |
11,174
-22,623
| -67% | -$636K | ﹤0.01% | 3850 |
|
|
2020
Q3 | $990K | Buy |
33,797
+22,205
| +192% | +$650K | ﹤0.01% | 2227 |
|
|
2020
Q2 | $351K | Buy |
+11,592
| New | +$351K | ﹤0.01% | 3260 |
|